Elisartan

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C27H29ClN6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WCC8Z95027, chemically known as 1h-imidazole-5-carboxylic acid, 2-butyl-4-chloro-1-((2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)-, 1-((ethoxycarbonyl)oxy)ethyl ester but generally known as elisartan, which bears US NIH Compound Identifier 183766. European Medicines Agency schedules Elisartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06487MIG. The term ELISARTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). ELISARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule elisartan under HS 29332990 and SITC 51573. As of Q4 2014, ELISARTAN remains the US FDA Preferred Term for this commodity. Elisartan bears US NLM identifiers UMLS ID C2348398 and NCI Concept Code C72933. SMILES: Clc1nc(n(Cc2ccc(cc2)c2c(cccc2)c2n[nH]nn2)c1C(=O)OC(OC(=O)OCC)C)CCCC.